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Abstract
NR2B-containing NMDA (NR2B/NMDA) receptors are important in controlling neurogenesis and are involved in generating
spatial memory. Ro25-6981 is a selective antagonist at these receptors and actuates neurogenesis and spatial memory. Inter-
structural neuroanatomical profiles of gene expression regulating adult neurogenesis and neuroapoptosis require examination in
the context of memory retrieval and reversal learning. The aim was to investigate spatial memory retrieval and reversal learning in
relation to gene expression-linked neurogenetic processes following blockade of NR2B/NMDA receptors by Ro25-6981. Rats were
trained in Morris water maze (MWM) platform location for 5 days. Ro25-6981 was administered (protocol days 6–7) followed by
retraining (days 15–18 or 29–32). Platform location was tested (on days 19 or 33) then post-mortem brain tissue sampling (on days
20 or 34). The expression of three genes known to regulate cell proliferation (S100a6), differentiation (Ascl1), and apoptosis (Casp-
3) were concomitantly evaluated in the hippocampus, prefrontal cortex, and cerebellum in relation to the MWM performance
protocol. Following initial training, Ro25-6981 enhanced visuospatial memory retrieval performance during further retraining
(protocol days 29–32) but did not influence visuospatial reversal learning (day 33). Hippocampal Ascl1 and Casp-3 expressions
were correspondingly increased and decreased while cerebellar S100a6 and Casp-3 activities were decreased and increased respec-
tively 27 days after Ro25-6981 treatment. Chronological analysis indicated a possible involvement of new mature neurons in the
reconfiguration of memory processes. This was attended by behavioral/gene correlations which revealed direct links between spatial
memory retrieval enhancement and modified gene activity induced by NR2B/NMDA receptor blockade and upregulation.
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Introduction
Recent evidence has implicated N-methyl-d-aspartate recep-
tors (NMDARs) in several aspects of learning ability and
behavioral flexibility in rodents (Delgado-García and Gruart
2017; Zhou and Wollmuth 2017). In addition, it has been
demonstrated that NMDARs are important not only for the
acquisition of new memories but also for the decay of mem-
ories acquired previously (Shinohara and Hata 2018). There is
also ample evidence that neurogenesis (proliferation, differen-
tiation, and migration of both neuronal and glial cells) occurs
in the adult brain, notably in anatomical structures which are
associated with learning and memory (Toda and Gage 2018;
Ming and Song 2011; Nicola et al. 2015: Opendak and Gould
2015).
Data concerning the plasticity and potential of adult neural
stem and progenitor cells has accumulated over the years. It is
known that alongside astrocyte gene expression (Lisachev et
al. 2010), these cells can give rise not only to neurons but also
to astrocytes, reactive astrocytes, and ultimately to oligoden-
drocytes through genetic manipulation (Encinas and
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Fitzsimons 2017). In this connection, newborn neurons are
integrated in neuronal pre-existing nets and underlie new
skills whereby their survival, apoptotic death, and extent of
maturation are contingent upon the overall environmental and
metabolic conditions (Kee et al. 2007; Kempermann 2012;
Encinas et al. 2013). Moreover, the involvement of new neu-
rons in learning and memory mechanisms is also determined
by their degree of maturity (Deng et al. 2010; Richetin et al.
2015). The excitatory amino-acid glutamate is known to reg-
ulate adult neurogenesis in the hippocampus. This neurotrans-
mitter operates through NMDA receptors, whichmodulate not
only the proliferation of progenitor cells but also the rate of
neurogenesis in the dentate gyrus (Nácher andMcEwen 2006;
Nácher et al. 2007; Thakurela et al. 2015). Consequently,
stimulation of NMDA receptors reduces neurogenesis while
NMDA antagonism has the reverse effect (Cameron et al.
1995). However, the mechanisms by which these processes
influence memory formation are not well established.
One experimental approach for studying the role of new-
born cells in integrative brain activity involves stimulation or
blockade of neurogenetic stages. NMDA blockade in particu-
lar promotes neuronal propagation in the hippocampus
(Cameron et al. 1995; Okuyama et al. 2004) both in the young
as well as the aged state (Nácher et al. 2003; Nácher and
McEwen 2006). The physiological actions of NMDA recep-
tors largely depend on the constituent NR2 subunits, and in
the hippocampus, NR2A/B subunits by themselves exemplify
macromolecular complexes with NR1 (Kiselycznyk et al.
2015). The NR2B subunit is prevalent in human and animal
neural stem cells, and it has been postulated that NMDA re-
ceptors comprising this subunit may be essential in controlling
neuronal propagation and memory (Hu et al. 2008; Nakazawa
et al. 2004). In the late 1980s, a new class of NMDA antago-
nists, typified by the phenylethanolamine ifenprodil, was
identified (Chenard andMenniti 1999). In this regard, ensuing
pharmacological manipulation with selective antagonists at
NMDA receptors incorporating the NR2B subunit (NR2B/
NMDA receptors) such as the potent, selective, and activity-
dependent antagonist of NR2B/NMDA receptors, namely
Ro25-698, has been studied (Fischer et al. 1997; Lynch et al.
2001. Szczurowska and Mareš 2015). In animals, the NR2B
subunit is expressed in cell precursors which are localized in
different brain areas and differentiated into granular neurons
in the hippocampus (Nácher et al. 2007). It has been shown
that in mice, Ro25-6981 instigates an increase in the quantity
of newly born BrdU-labeled cells at the 29–34-day-old stage
in the rat hippocampal dentate gyrus. This result correlated
with facilitated expression of visuospatial skill in the Morris
water maze (MWM) (Hu et al. 2008). However, it was also
discovered that there was an increase in 1–6-day-old novel
cells which did not influence learning and memory processes
(Hu et al. 2008). Along with the functional role of different
aged cells developed in post-natal ontogenesis, considerable
interest has been focused on the learning ability of animals and
the degree of neurogenesis (Storozheva et al. 2015). It has
been reported that in individuals with a high capacity for
learning, greater numbers of newborn cells are generated
and survive in comparison with individuals displaying lower
learning capacities (Coras et al. 2010). In earlier studies, it has
also been disclosed that Ro25-6981 in a dose which is known
to stimulate neurogenesis (Hu et al. 2008) did not influence
repeated and reversal learning when administered directly be-
fore repeated training (Soloviova et al. 2012). However,
Ro25-6981 facilitated the formation of spatial skill in those
animals with initial inferior learning ability (Soloviova et al.
2011). More recent data has suggested that spatial reversal
learning is sensitive to Ro25-6981 whereby NR2B/NMDA
receptor signaling may be implicated in behavioral plasticity
involved in updating spatial information (Clark et al. 2017).
Genetic regulation of short- and long-term memory is a
topical area of research. However, inter-structural neuroana-
tomical profiles of gene expression regulating adult
neurogenesis and neuroapoptosis require special consider-
ation in the context of memory. The expression of three genes
known to regulate cell proliferation (S100a6), differentiation
(Ascl1), and apoptosis (Casp-3) have been concomitantly
evaluated in the rat hippocampus, prefrontal cortex, and cere-
bellum with respect to water maze spatial memory perfor-
mance. The gene expression outcome patterns supported the
concept of a hippocampal involvement in the acquisition of
memory in addition to a complementary connection between
the prefrontal cortex and cerebellum (Gruden et al. 2013)
In light of this, there are no data concerning NR2B/NMDA
receptor antagonism on gene expression implicated in
neurogenesis and neuroapoptosis in different brain structures
either in naïve animals or during consolidation and
reconsolidation of spatial performance. Therefore, the aim
was to study spatial memory retrieval, reversal learning, and
gene expression following blockade of NR2B/NMDA recep-
tors by the neurogenesis actuator Ro25-6981 as a potential
memory enhancer. Regarding this point, hippocampal, pre-
frontal cortical and cerebellar brain areas were specifically
selected for study. This was because it has been previously
shown that there are integrative relationships between Casp3,
Ascl1, and S100a6 genes in all three of these neuroanatomical
structures with respect to spatial memory (Gruden et al. 2013)
Experimental Procedures
All experimental procedures were carried out in accordance
with the National Institute of Health Guide for the Care and
Use of Laboratory Animals (NIH publication No 80-23, re-
vised 1996). They also conformed to the UK Animal
Scientific Procedures Act, as well as the European
Community Council Directive (86/609/EEC). They were
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additionally approved by the Animal Care and Use
Committee of the Federal State Budgetry Research P. K.
Anokhin Research Institute of Normal Physiology.
Ro25-6981 (αR,βS)-α-(4-hydroxyphenyl)-β-methyl-
4-(phenylmethyl)-1-piperidinepropanol maleate was supplied
by Sigma-Aldrich, USA.
Animals
Age-matched male Wistar rats weighing 230 ± 20 g (n = 98)
were randomly allocated to the following groups:
Group 1: MWM training animals that underwent water
maze training without any treatment; group 2: active controls
that were non-injected untrained animals allowed to act as
swim controls; group 3: training animals 14 days post-Ro25-
6981 dosing; group 4: training animals 14 days post-saline
vehicle injection; group 5: training animals 28 days post-
Ro25-6981 administration; group 6: training animals 28 days
post-saline vehicle injection; group 7: naïve rats killed 14 days
after Ro25-6981 administration plus post-mortem brain tissue
sampling; group 8: naïve rats killed 14 days after saline vehi-
cle administration plus post-mortem brain tissue sampling;
group 9: naïve rats killed 28 days after Ro25-6981 adminis-
tration plus post-mortem brain tissue sampling; group 10:
naïve rats killed 28 days after saline vehicle administration
plus post-mortem brain tissue sampling. Each group consisted
of a minimum of 10 up to a maximum of 14 animals.
Drug Administration
In animals from experimental groups 3, 5, 7, and 9, Ro25-
6981 (5.0 mg/kg) dissolved in saline vehicle was administered
intraperitoneally (i.p.) (Hu et al. 2008; Duffy et al. 2008). All
control groups were administered an identical volume of sa-
line vehicle (1.0 ml/kg). Injections were performed twice, the
first being given 24 h after the last session of initial training
and the second 24 h later (i.e., protocol days 6 and 7 in Fig. 1).
Water Maze Paradigm
The water maze was comprised of a gray pool (circular in
shape and height 60 cm × 80 cm radius) marked into four
quadrants containing water (22.0 ± 1.0 °C) to a 40-cm depth
and rendered opaque by the addition of a small quantity of
powdered milk, and there were external cues from the room
(Gruden et al. 2013; Sewell et al. 2005). A clear Perspex
escape platform (radius = 12 cm) was located in the center of
one quadrant at a 2.0-cm depth. Assessment of task perfor-
mance in the MWM was carried out with the aid of video
monitoring, and initial training was accomplished over proto-
col days 1–5 (Fig. 1).
In each trial, the time taken to escape onto the hidden plat-
form (swimming latency, s) within 60 s was recorded and
followed by a 15-s occupation period on the platform, the
intertrial interval being 60 s.
Each training session consisted of five successive trials,
there being an intertrial period of 60 s with the platform posi-
tion in the center of the quadrant, and individual trials in-
volved random placement in a quadrant devoid of the plat-
form. Escape latency onto the platform within a period of 60 s
was logged then followed by a rest period before the next trial.
Animals which did not find the platform were gently directed
to the platform and allowed a 15-s occupancy time before
resting. The active control group was encouraged to swim
with the platform removed over the 5-day training period.
Training, Dosing, Testing, and Tissue Sampling
Protocols
Protocol (i)
Initial water maze training was performed daily for the first
5 days, then on days 6 and 7, animals were administered either
saline vehicle or Ro25-6981 (5.0 mg/kg) intraperitoneally
(Soloviova et al. 2011, 2012) followed by a modified behavior-
al protocol. Henceforth, daily repeated training was implement-
ed on days 15–18 inclusively followed on day 19 by a platform
relocation test (reversal learning) and later tissue sampling was
performed on day 20 from post-mortem brains (Fig. 1).
Fig. 1 Scheme showing the experimental protocols. Protocol (i). On days
1–5, rats underwent daily initial training in the Morris water maze
(MWM) followed on days 6 and 7 by Ro25-6981 (5.0 mg/kg i.p.)
administration, then daily repeated training on days 15–18. On day 19,
the animals were exposed to a platform relocation test (reversal learning).
Lastly, on day 20, animals were killed and post-mortem regional brain
samples were obtained. Protocol (ii). On days 1–5, rats underwent daily
initial training in the Morris water maze (MWM) followed on days 6 and
7 by Ro25–6981 (5.0 mg/kg i.p.) administration, then daily repeated
training on days 29–32. On day 33, the animals were exposed to a
platform relocation test (reversal learning). Lastly, on day 34, animals
were killed and post-mortem regional brain samples were obtained
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Protocol (ii)
Initial water maze training was carried out daily for the first
5 days, then on days 6 and 7, animals were administered either
saline vehicle or Ro25-6981 (5.0 mg/kg) intraperitoneally
(Soloviova et al. 2011, 2012) followed by a modified behav-
ioral protocol. Thus, daily repeated training was implemented
on days 29–32 inclusively followed on day 33 by a platform
relocation test (reversal learning) and subsequent tissue sam-
pling on day 34 from post-mortem brains (Fig. 1).
Real-Time PCR Analysis
The day subsequent to the last platform relocation reversal
learning water maze test (i.e., the 20th day in protocol (i) or
the 34th day in protocol (ii)), animals were killed and brain
structures dissected on ice. Using our published procedure,
RNA from brain structures was isolated and purified from a
genome DNA admixture by DNase 1 treatment and the RNA
concentration determined fluorometrically by means of a
Qubit RNA Assay Kit (Invitrogen, USA). Reverse transcrip-
tion was then accomplished using RNA (50 ng), revertase M-
MLV (200 U), and oligo-(dT) 15 plus RNAse inhibitor at
37 °C for 105 min, the resulting DNA being diluted (×10)
then freeze stored. Real-time PCR was performed repetitively
on samples containing diluted cDNA (1.0 μl), ready primer
mixture (0.5 μl), qPCRmix-HS SYBR (5.0 μl), qPCRmix-HS
SYBR (5.0 μl), and deionized water made up to 25.0 μl ac-
cording to our previously described protocol (Gruden et al.
2013). Evaluation of gene expression levels were executed
using the β-actin gene as a reference (Joo et al. 2008) and
calculated according to Livak and Schmittgen (2001).
Statistics
Repeated-measures ANOVA was used for behavioral results
analysis and the Mann-Whitney U test utilized to verify sta-
tistical differences in mRNA expression. Spearman’s rank co-
efficient (rS) computation was employed to identify any pos-
sible correlations among brain structure mRNA expressions.
Results
Behavior
Performance in Daily Initial Pre-Drug Training, Then Repeated
Training and a Reversal Learning Test in the Morris Water
Maze after Ro25-6981 Treatment
In the initial 5-day phase of training in protocol (i), there were
no significant differences in platform latencies among control
or experimental groups at any time before drug administration
(Fig. 2). In the initial 5-day phase of the training protocol: (i)
there was a significant effect of training day [F(4, 87) = 25.06,
P < 0.001] but no effect of group [F(2.21) = 0.06, P > 0.1] or
group × trial interaction [F(4, 87) = 0.49, P > 0.1] was
observed.
Fig. 2 Latency to reach the platform for rats in the water maze (MWM)
during initial training and after Ro25-6981 administration in retraining
(further training) and the reversal learning procedure (RLP) in protocol (i)
and (ii). Protocol (i). Mean MWM platform latencies (s) are shown for
training days 1–5 then Ro25-6981 (5.0 mg/kg i.p.) or saline vehicle
(1.0 ml/kg i.p.) administration on days 6 and 7 followed by retraining
on days 15–18 and the MWM platform relocation test (MWM PRT, i.e.,
reversal learning) on day 19. Protocol (ii). Mean MWM platform
latencies (s) are shown for training days 1–5 then Ro25-6981 (5.0 mg/
kg i.p.) or saline vehicle (1.0 ml/kg i.p.) administration on days 6 and 7
followed by retraining on days 29–32 and the MWM platform relocation
test (MWMPRT, i.e., reversal learning) on day 33. *P < 0.05 compared to
saline vehicle-treated control animals
J Mol Neurosci
After Ro25-6981 treatment, in the first 2 days of repeated
learning (repeated training days 15 and 16 in Fig. 2), animals
in both experimental groups were not significantly different in
their platform latencies. Additionally, on repeated training
days 17 and 18, the platform latencies had returned to the
day 5 pre-drug levels. Repeated-measures one-way ANOVA
revealed a significant effect of the retraining day [F(3.65) =
13.07, P < 0.001] but no effect of group [F(2.21) = 0.02, P >
0.1] or group × trial interaction [F(4.87) = 0.61, P > 0.1] was
observed.
What is more, throughout the whole protocol, there
were no differences between the platform location times
expressed in animals after Ro25-6981 administration
compared with saline controls and this absence of differ-
ence persisted even in the platform relocation test (rever-
sal learning) [F(2.21) = 0.5, P > 0.1] (i.e., day 19, Fig. 2).
Similar results were obtained when the distance to reach
platform was analyzed (Fig. 3).
In protocol (ii) similarly, there were no differences in plat-
form location times between animal groups in the first 5 days
of initial training. The effect of training day was highly sig-
nificant [F(4.88) = 34.52, P < 0.001], but no effect of group
[F(2.22) = 1.72, P > 0.1] or group × day interaction [F(4.88) =
1.15, P > 0.1] was observed.
After Ro25-6981 treatment, on the first 2 days of re-
peated learning (repeated training days 15 and 16 in Fig.
2), animals in both experimental groups were not signif-
icantly different in their platform latencies [F(2.22) =
1.89, P > 0.1]. However, repeated-measures one-way
ANOVA revealed a signif icant effect of group
[F(4.88) = 3.78, P < 0.05], day [F(3.66) = 23.45, p <
0.001], and group × day interaction [F(4.88) = 4.39, P <
0.01].
Post hoc analysis revealed that the saline and drug-treated
group latencies then began to diverge on day 30 and this
consequent Ro25-6981-induced differential attained statistical
significance (P < 0.05) on days 30, 31, and 32 of the protocol
though there was no disparity detected in the platform reloca-
tion test (reversal learning) (i.e., day 33, Fig. 2). [F(1.22) =
1.04, P > 0.1].
Similar results were obtained when the distance to reach
the platform was analyzed (Fig. 3).
Gene Expression
Ascl1, S100a6, and Casp3 Gene Expression Analysis
In molecular genetic experiments, we have previously re-
ported brain regional specificities in Ascl1, S100a6, and
Casp3 gene expression within the prefrontal cortex, hip-
pocampus, and cerebellum (Gruden et al. 2013). In the
current study, gene expression was examined in the same
brain areas 14 and 28 days after Ro25-6981 (5.0 mg/kg
i.p.) administration in parallel with initial pre-treatment
training, post-treatment repeated training followed on
day 19 or 33 by a platform relocation test (reversal learn-
ing) in the Morris water maze.
Fig. 3 Distance to reach the platform for rats in the water maze (MWM)
during initial training and after Ro25-6981 administration in retraining
(further training) and the reversal learning procedure (RLP) in protocol (i)
and (ii). Protocol (i). Mean distance (cm) to reach MWM platform are
shown for training days 1–5 then Ro25-6981 (5.0 mg/kg i.p.) or saline
vehicle (1.0 ml/kg i.p.) administration on days 6 and 7 followed by
retraining on days 15–18 and the MWM platform relocation test
(MWM PRT, i.e., reversal learning) on day 19. Protocol (ii). Mean
distance (cm) to reach MWM platform location times (s) are shown for
training days 1–5 then Ro25-6981 (5.0 mg/kg i.p.) or saline vehicle
(1.0 ml/kg i.p.) administration on days 6 and 7 followed by retraining
on days 29–32 and the MWM platform relocation test (MWM PRT, i.e.,
reversal learning) on day 33. *P < 0.05 compared to saline vehicle-treated
control animals
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Ascl1 Expression 14 and 28 Days after Ro25-6981 Double
Treatment Commencing on Protocol Day 6
Examination of Ascl1 transcription in the three brain areas
disclosed that expression levels were not changed 14 days
after protocol day 6 and 7 treatments in groups receiving
Ro25-6981 or saline plus training and Ro25-6981 without
training in comparison with the controls (Fig. 4).
However, 28 days after treatment, hippocampal Ascl1 ex-
pression levels only were elevated (P < 0.05) in those an-
imals receiving Ro25-6981 plus training compared to
those administered Ro25-6981 or the controls without
training and saline plus training. In the case of the
prefrontal cortex and cerebellum, there were no differ-
ences in expression levels of Ascl1 between all groups
and compared to controls 28 days following treatment
(Fig. 5).
S100a6 Expression 14 and 28 Days after Ro25-6981 Double
Treatment Commencing on Protocol Day 6
Fourteen days after double-drug treatment starting on protocol
day 6, there were no differences in S100a6 gene expression
between any of the animal groups and also compared to the
controls in the three brain structures under study (Fig. 6). This
absence of modified gene expression with respect to brain
Fig. 4 Ascl1 gene expression in
rat hippocampus, cerebellum, and
prefrontal cortex 14 days after 2-
day treatment with Ro25-6981
(5.0 mg/kg i.p.) with or without
training compared to controls
with or without training. Ascl1
gene expression (relative units) in
saline non-trained control animal
brain structures (dotted lines).
Points shown are medians with
boxes displaying upper and lower
interquartile range values
Fig. 5 Ascl1 gene expression in
rat hippocampus, cerebellum, and
prefrontal cortex 28 days after 2-
day treatment with Ro25-6981
(5.0 mg/kg i.p.) with or without
training compared to controls
with or without training. Ascl1
gene expression (relative units) in
saline non-trained control animal
brain structures (dotted lines).
Points shown are medians with
boxes displaying upper and lower
interquartile range values. *P <
0.05 versus Ro25-6981 + no
training, #P < 0.05 versus control
(dotted line), §P < 0.05 versus
saline + training
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structure differed from the pattern observed 28 days after drug
treatment where the expression of S100a6 was considerably
diminished (P < 0.05) in comparison with the other groups as
well as the controls exclusively in the cerebellum (Fig. 7). It
was also noted that there were no significant changes in hip-
pocampal or prefrontal cortical S100a6 expression observed
in any of the treated groups (Fig. 7).
Casp-3 Expression 14 and 28 Days after Ro25-6981 Double
Treatment Commencing on Protocol Day-6
In the case of Casp-3 transcription 14 days after double-
drug treatment (protocol days 6 and 7), in the
hippocampus, there was a marked inhibition of its expres-
sion in the animals which received Ro25-6981 along with
training compared to those given Ro25-6981 without any
training. In addition, there was an increase in Casp-3 ex-
pression in subjects which underwent training coupled
with saline administration versus the controls. On the oth-
er hand, in the cerebellum, there was a contrasting profile
because the expression of Casp-3 in the group given
Ro25-6981 plus training, rather than being reduced, it
was significantly elevated (P < 0.05) in comparison not
only with controls but also with those individuals given
saline plus training and Ro25-6981 without training
(Fig. 8). There was an almost identical pattern of
Fig. 6 S100a6 gene expression in
rat hippocampus, cerebellum, and
prefrontal cortex 14 days after 2-
day treatment with Ro25-6981
(5.0 mg/kg i.p.) with or without
training compared to controls
with or without training. S100a6
gene expression (relative units) in
saline non-trained control animal
brain structures (dotted lines).
Points shown are medians with
boxes displaying upper and lower
interquartile range values
Fig. 7 S100a6 gene expression in
rat hippocampus, cerebellum, and
prefrontal cortex 28 days after 2-
day treatment with Ro25-6981
(5.0 mg/kg i.p.) with or without
training compared to controls
with or without training. S100a6
gene expression (relative units) in
saline non-trained control animal
brain structures (dotted lines).
Points shown are medians with
boxes displaying upper and lower
interquartile range values. *P <
0.05 versus Ro25-6981 + no
training, #P < 0.05 versus control
(dotted line), §P < 0.05 versus
saline + training
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outcomes 28 days after double-drug treatment (Fig. 9) in
the hippocampus, and Casp-3 expression was reduced in
the group treated with Ro25-6981 plus training compared
to saline with training as well as the controls. Analogous
to the 14-day results in the cerebellum, at 28 days after
dual treatment, there was a marked increase in cerebellar
Casp-3 transcription but no change in the prefrontal
cortex.
Correlation Analyses between Gene Expression
and Behavioral Swimming Intervals
Protocol day independent correlation analyses between gene
expression and behavioral swimming intervals after drug
treatment were performed. Thus, there was a negative corre-
lation between the unmodified prefrontal cortical Ascl1 ex-
pression and overall repeated training swimming time (rs =
Fig. 8 Casp-3 gene expression in
rat hippocampus, cerebellum, and
prefrontal cortex 14 days after 2-
day treatment with Ro25-6981
(5.0 mg/kg i.p.) with or without
training compared to controls
with or without training. Casp-3
gene expression (relative units) in
saline non-trained control animal
brain structures (dotted lines).
Points shown are medians with
boxes displaying upper and lower
interquartile range values. *P <
0.05 versus Ro25-6981 + no
training, #P < 0.05 versus control
(dotted line), §P < 0.05 versus
saline + training
Fig. 9 Casp-3 gene expression in
rat hippocampus, cerebellum, and
prefrontal cortex 28 days after 2-
day treatment with Ro25-6981
(5.0 mg/kg i.p.) with or without
training compared to controls
with or without training. Casp-3
gene expression (relative units) in
saline non-trained control animal
brain structures (dotted lines).
Points shown are medians with
boxes displaying upper and lower
interquartile range values. *P <
0.05 versus Ro25-6981 + no
training, #P < 0.05 versus control
(dotted line), §P < 0.05 versus
saline + training
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− 0.515, t(N-2) = − 2.403, P = 0.029). There was also a posi-
tive correlation between hippocampal Casp-3 expression and
mean repeated training swimming time (rs = 0.505, t(N-2) = −
2.265, P = 0.039). In the cerebellum and prefrontal cortex,
Casp-3 gene expression negatively correlated with similar be-
havioral indicators (rs = − 0.484, t(N-2) = − 2.212, P = 0.042)
and (rs = − 0.476, t(N-2) = − 2.164, P = 0.046), respectively.
Additionally, post-Ro25-6981 treatment protocol day-
dependent correlation analyses revealed a negative correlation
between hippocampal Ascl1 expression and the mean time of
repeated training on the 14th post-treatment day (rs = − 0.714,
t(N-2) = − 2.500, P = 0.047). Furthermore, on the 28th post-
treatment day, there was a negative correlation between cere-
bellar Casp-3 expression and speed of reversal learning (rs =
− 0.750, t(N-2) = − 3.000, P = 0.019).
Summary of Gene Transcription Findings
There is a very complex pattern of results with respect to the
expression of genes in the study so the outcomes for Ascl1,
S100a6, and Casp-3 transcription in the three brain regions
taken from the animal group which were retrained and treated
with Ro25-6981 are presented in a more summarized form in
Fig. 10. Hence, the notable outcomes were that hippocampal
Ascl1 expression was increased in the animals 28 days after
Ro25-689 treatment, cerebellar S100a6 expression was de-
creased 28 days after Ro25-6981, and hippocampal Casp-3
expression was decreased both at 14 and 28 days after Ro25-
6981 administration. In contrast, cerebellarCasp-3 expression
was increased at 14 and 28 days after dosing with Ro25-6981.
There were no significant changes in the gene expressions in
the prefrontal cortex (Fig. 10).
Discussion
Multi-staged neurogenesis is important to learning processes
(Hu et al. 2009). It is controlled by NMDA receptors involv-
ing different pathways initiating proliferation through
CaMKIV phosphorylation and subsequent activation of
CREB in precursor cells and differentiating granule neurons
(Nácher andMcEwen 2006, Nácher et al. 2007; Li et al. 2011;
Bekiari et al. 2015). Correspondingly, findings concerning the
role of glutamate receptors in spatial memory mechanisms
support the hypothesis that their blockade may contribute to-
wards stimulation of the critical stages of neurogenesis
(Nácher and McEwen 2006; Hu et al. 2008).
Neurogenesis necessitates cellular progression from prolif-
eration to maturation over a period up to 30 days (Aasebø et al.
2011). Thus, in the current study, this cellular developmental
30-day epoch was selected to investigate the possible involve-
ment of different aged neuronal populations contributing to
processes of spatial navigation.
In this context, there has been a special focus upon the
NR2B subunit of NMDA receptors, antagonism of which ac-
tuates neurogenesis (Hu et al. 2008). In view of this, highly
selective antagonism at receptors carrying this subunit, Ro25-
6981 invokes a cascade of molecular events which involve
CREB activation (Li et al. 2011) followed by remodeling of
transcription regulation (Brown et al. 2011). Such outcomes
may well lead to functional activation of neurogenetic pro-
cesses which inevitably impact memory phenomena (Snyder
et al. 2005; Costa et al. 2015).
The current data provides evidence that the qualitative in-
fluence of Ro25-6981 on spatial memory performance is very
much a time-dependent entity over a period up to 28 days.
Accordingly, we found that during repeated training with a
Fig. 10 Summary tabulated
scheme showing the overall
influence of Ro25-6981 (5.0 mg/
kg i.p.) 14 and 28 days after
treatment on AScl1, S100a6, and





arrows = no significant change,
upward pointing arrows =
significant increase, and
downward pointing arrows =
significant decrease
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fixed platform location 9–12 days (i.e., protocol (i) days 15–
18, Fig. 1) after commencement of Ro25-6981 administration,
animal learning capability was not significantly modified in
comparison with controls. Likewise, injection of Ro25-6981
has been reported to have no effect on latency or path length to
a MWM platform over a 5-day training period after drug treat-
ment in mice (Duffy et al. 2008). However, in our study, 25–
26 days (i.e., protocol days 31–32) after Ro25-6981 initial
double dosing, there was an enhancement of platform perfor-
mance in the repeated learning session (Fig. 2). The differ-
ences in latency to reach the platform reflected differences in
travel distance to the platform (Fig. 3) but not the speed which
was not significantly different between groups. This data may
be associated with survival of newborn mature neurons which
were integrated into existing neuronal nets to participate in
processes underlying long-term visuospatial memory.
However, subsequent reversal learning was not established
on the 28th day (i.e., protocol (ii) day 33) after Ro25-6981
exposure. It may be postulated that the repeated learning pro-
cedure at the stage of reconsolidation of memory is character-
ized by activation of learning speed. These findings concur
with data that administration of Ro25-6981 (10 mg/kg) selec-
tively impairs the early phase of reversal learning. In view of
this, spatial reversal learning but not set-shifting has been
shown to be sensitive to Ro-25-6981 treatment (Clark et al.
2017). Additionally, it is of note from our findings that block-
ade of NR2B/NMDA receptors subsequently discloses a stim-
ulant effect on memory reconsolidation at the repeated train-
ing stage of the experimental protocol where stored memories
become more labile. On this matter, the converse has been
demonstrated that blockade of reconsolidation results in per-
manent amnesia (Nader and Hardt 2009; Lee 2009).
Furthermore, recent data has suggested that molecular mech-
anisms which are prompted during the initial stage of recall
actually operate to restrict the early extinction of memory
(Trent et al. 2015).
Gene expression of protein participants (Casp-3, Ascl1,
and S100a6) involved in regulation of the proliferation and
differentiation stages of neurogenesis has been previously im-
plicated in visuospatial memory formation (Gruden et al.
2013). The present findings signify complex chronological
and interstructurally linked brain gene expression associations
with hippocampal-dependent memory. Thus, in the hippo-
campus, prefrontal cortex, and cerebellum, 14 days after initial
Ro25-6981 injection, the expression of S100a6 and Ascl1 in
trained animals did not differ from controls. Therefore, it may
be postulated that blockade of NR2B/NMDA receptors is not
crucial to modification of the proliferation and differentiation
stages of neural development but may be important to the
survival of differentiated neurons. This notion is supported
by our data concerning the constrained expression of Casp-3
in the hippocampus (14-day post-treatment) where a decrease
in neuronal apoptosis is reciprocated by newborn cell survival
and/or increased hippocampal plastic remodeling (Bailey et al.
2015). The opposite effect regarding Casp-3 expression was
found in the cerebellum which is involved not only in motor
behavior (Swinny et al. 2005) but also spatial memory forma-
tion (Reeber et al. 2013). Hence, a significant increase in
Casp-3 expression in this brain area (Figs. 8, 9, and 10) might
be correlated predominantly with motor circuitry. Recently
however, it has been disclosed that blockade of NMDA recep-
tors represses the glutamatergic contribution to cellular differ-
entiation and growth needed for newborn GABA neuronal
survival resulting in a shift towards apoptosis (Roux et al.
2015). Twenty-eight days post-Ro25-6981 treatment, a hippo-
campal elevation of Ascl1 expression was observed, and this
was associated with learning enhancement during repeated
training. It is noteworthy that 28 days after Ro25-6981 dosing,
an increased neuronal differentiation from elevatedAscl1 gene
activity in the hippocampus contrasted with inhibition of pro-
liferation and S100a6-associated repeated training gene ex-
pression in the cerebellum. Interestingly, Casp-3 expression,
which is likely to be linked with programmed cell death and
neural plasticity, was inhibited in the hippocampus but also
markedly elevated in the cerebellum during the repeated train-
ing procedure 28 days after drug administration (Figs. 8, 9,
and 10).
Arising from the gene expression/behavior correlation
analyses, it was deduced that prefrontal cortical Ascl1 expres-
sion is linked with individual capacities for learning which are
not dependent on Ro25-6981 effect chronology in the current
protocols. Hippocampal Ascl1 and Casp-3 expressions appear
to be implicated in the early stages of memory formation dur-
ing repeated training. This contrasts with cerebellar Casp-3
expression, which is crucial to later stages along with in-
creased repeated training or reversal learning speed (i.e., ele-
ments of neural plasticity which are connected with a strategy
to find the platform). It was also concluded that increased
prefrontal cortical Ascl1 and Casp-3 expression along with
cerebellar Casp-3 accompany rapid learning during repeated
training. However, high levels of hippocampalCasp-3 expres-
sion may be associated with slow learning during repeated
training.
Clinical aspects of morbidity connected with human spatial
memory have directed attention to higher mammals. It has
been documented that chimpanzees have larger hippocampal
and cerebellar volumes relative to bonobo apes (Hopkins et al.
2009). This may be related to a wider home range (≤ 560 km2)
in chimpanzees (Shefferly 2005) likely to impose a bigger
demand on spatial memory (Hassabis et al. 2009) versus the
bonobos smaller home range (≤ 60 km2) (Hopkins et al. 2009;
Fruth et al. 2016). These observations are accompanied by an
expansion of knowledge regarding adult neurogenesis in the
hippocampus (Kempermann 2012) and cerebellum (Gruden et
al. 2013) though this developmental component is not well
established in humans (Bergmann et al. 2015). Selective
J Mol Neurosci
blockade and/or upregulation of NR2B/NMDA receptors
gives rise to improvedmemory retrieval aptitude through gene
regulation of basic cell birth and death processes, and involve-
ment of new mature neurons. These findings are therefore
manifestly incentive towards future diagnosis and treatment
strategies for clinical cognitive deficits.
Conclusions
In summary, Ro25-6981 blockade of NR2B/NMDA receptors
enhanced spatial memory retrieval in rats but did not influence
visuospatial reversal learning. It also modified brain S100a6,
Ascl1, and Casp-3 cell regulator gene expression and in all
probability actuated neurogenesis possibly implicating new
mature neurons in memory retrieval.
Funding information Funding for this work was provided by the P.K.
Anokhin Institute of Normal Physiology.
Compliance with Ethical Standards
Conflict of Interest The authors declare that they have no conflicts of
interest.
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give appro-
priate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made.
References
Aasebø IE, Blankvoort S, Tashiro A (2011) Critical maturational period
of new neurons in adult dentate gyrus for their involvement in mem-
ory formation. Eur J Neurosci 33:1094–1100. https://doi.org/10.
1111/j.1460-9568.2011.07608.x
Bailey CH, Kandel ER, Harris KM (2015) Structural components of
synaptic plasticity and memory consolidation. Cold Spring Harb
Perspect Biol, 7(7): a021758. doi: https://doi.org/10.1101/
cshperspect.a021758
Bekiari C, Giannakopoulou A, Siskos N, Grivas I, Tsingotjidou A,
Michaloudi H, Papadopoulos GC (2015) Neurogenesis in the septal
and temporal part of the adult rat dentate gyrus. Hippocampus 25:
511–523. https://doi.org/10.1002/hipo.22388
Bergmann O, Spalding KL, Frisén J (2015) Adult neurogenesis in
humans. Cold Spring Harb Perspect Biol 7(7):a018994. https://doi.
org/10.1101/cshperspect.a018994
Brown TE, Lee BR, Mu P, Ferguson D, Dietz D, Ohnishi YN, Lin Y,
Suska A, Ishikawa M, Huang YH, Shen H, Kalivas PW, Sorg BA,
Zukin RS, Nestler EJ, Dong Y, Schlüter OM (2011) A silent
synapse-based mechanism for cocaine-induced locomotor sensitiza-
tion. J Neurosci 31:8163–8174. https://doi.org/10.1523/
JNEUROSCI.0016-11.2011
Cameron HA, McEwen BS, Gould E (1995) Regulation of adult
neurogenesis by excitatory input and NMDA receptor activation in
the dentate gyrus. J Neurosci 15:4687–4692
Chenard BL, Menniti FS (1999) Antagonists selective for NMDA recep-
tors containing the NR2B subunit. Curr Pharm Des 5:381–404
Clark E, Antoniak K, Feniquito A, Dringenberg HC (2017) Effects of the
GluN2B-NMDA receptor antagonist Ro 25-6981 on two types of
behavioral flexibility in rats. Behav Brain Res 319:225–233. https://
doi.org/10.1016/j.bbr.2016.11.032
Coras R, Siebzehnrubl FA, Pauli E, Huttner HB, Njunting M, Kobow K,
Villmann C, Hahnen E, Neuhuber W, Weigel D, Buchfelder M,
Stefan H, Beck H, Steindler DA, Blümcke I (2010) Low prolifera-
tion and differentiation capacities of adult hippocampal stem cells
correlate with memory dysfunction in humans. Brain 133:3359–
3372. https://doi.org/10.1093/brain/awq215
Costa V, Lugert S, Jagasia R (2015) Role of adult hippocampal
neurogenesis in cognition in physiology and disease: pharmacolog-
ical targets and biomarkers. Handb Exp Pharmacol 228:99–155.
https://doi.org/10.1007/978-3-319-16522-6_4
Delgado-García JM, Gruart A (2017) Learning as a functional state of the
brain: studies in wild-type and transgenic animals. Adv Exp Med
Biol 1015:75–93. https://doi.org/10.1007/978-3-319-62817-2_5
Deng W, Aimone JB, Gage FH (2010) New neurons and new memories:
how does adult hippocampal neurogenesis affect learning and mem-
ory? Nat Rev Neurosci 11:339–350. https://doi.org/10.1038/
nrn2822
Duffy S, Labrie V, Roder JC (2008) D-serine augments NMDA-NR2B
receptor-dependent hippocampal long-term depression and spatial
reversal learning. Neuropsychopharmacology 33:1004–1018.
https://doi.org/10.1038/sj.npp.1301486
Encinas JM, Fitzsimons CP (2017) Gene regulation in adult neural stem
cells. Current challenges and possible applications. Adv Drug Deliv
Rev 120:118–132. https://doi.org/10.1016/j.addr.2017.07.016
Encinas JM, Sierra A, Valcárcel-Martín R, Martín-Suárez SA (2013)
Developmental perspective on adult hippocampal neurogenesis.
Int J Dev Neurosci 3:640–645. https://doi.org/10.1016/j.ijdevneu.
2013.04.001
Fischer G,Mutel V, Trube G,Malherbe P, Kew JN, Mohacsi E, Heitz MP,
Kemp JA (1997) Ro 25-6981, a highly potent and selective blocker
of N-methyl-D-aspartate receptors containing the NR2B subunit.
Characterization in vitro. J Pharmacol Exp Ther 2833:1285–1292
Fruth B, Hickey JR, André C, Furuichi T, Hart J, Hart T, Kuehl H,
Maisels F, Nackoney J, Reinartz G, Sop T, Thompson J,
Williamson EA (2016) Pan paniscus (errata version published in
2016). The IUCN Red List of Threatened Species 2016:
e.T15932A102331567. https://doi.org/10.2305/IUCN.UK.2016-2.
RLTS.T15932A17964305.en. Downloaded on 12 January 2018
Gruden MA, Storozheva ZI, Sewell RDE, Kolobov VV, Sherstnev VV
(2013) Distinct functional brain regional integration ofCasp3, Ascl1
and S100a6 gene expression in spatial memory. Behav Brain Res
252:230–238. https://doi.org/10.1016/j.bbr.2013.06.024
Hassabis D, Chu C, Rees G, Weiskopf N, Molyneux PD, Maguire EA
(2009) Decoding neuronal ensembles in the human hippocampus.
Curr Biol 19:1–9. https://doi.org/10.1016/j.cub.2009.02.033
Hopkins WD, Lyn H, Cantalupo C (2009) Volumetric and lateralized
differences in selected brain regions of chimpanzees (Pan
troglodytes) and bonobos (Pan paniscus). Am J Primatol 71:988–
997. https://doi.org/10.1002/ajp.20741
HuM, Sun YJ, Zhou QG, Chen L, Hu Y, Luo CX, Wu JY, Xu JS, Li LX,
Zhu DY (2008) Negative regulation of neurogenesis and spatial
memory by NR2B-containing NMDA receptors. J Neurochem
106:1900–1913. https://doi.org/10.1111/j.1471-4159.2008.05554.x
HuM, Sun YJ, Zhou QG, Auberson YP, Chen L, Hu Y, Luo CX, Wu JY,
Zhu DY, Li LX (2009) Reduced spatial learning in mice treated with
NVP-AAM077 through down-regulating neurogenesis. Eur J
Pharmacol 622:37–44. https://doi.org/10.1016/j.ejphar.2009.09.031
J Mol Neurosci
Joo JH, Yoon SY, Kim JH, Paik SG, Min SR, Lim JS, Choe IS, Choi I,
Kim JW (2008) S100A6 (calcyclin) enhances the sensitivity to ap-
optosis via the upregulation of caspase-3 activity in Hep3B cells. J
Cell Biochem 103:1183–1197. https://doi.org/10.1002/jcb.21496
Kee N, Teixeira CM, Wang AH, Frankland PW (2007) Preferential in-
corporation of adult-generated granule cells into spatial memory
networks in the dentate gyrus. Nat Neurosci 10:355–362. https://
doi.org/10.1038/nn1847
Kempermann G (2012) New neurons for ‘survival of the fittest’. Nat Rev
Neurosci 13:727–736. https://doi.org/10.1038/nrn3319
Kiselycznyk C, Jury NJ, Halladay LR, Nakazawa K, Mishina M,
Sprengel R, Grant SG, Svenningsson P, Holmes A (2015) NMDA
receptor subunits and associated signaling molecules mediating
antidepressant-related effects of NMDA-GluN2B antagonism.
Behav Brain Res 287:89–95. https://doi.org/10.1016/j.bbr.2015.03.
023
Lee JL (2009) Reconsolidation: maintaining memory relevance. Trends
Neurosci 32:413–420. https://doi.org/10.1016/j.tins.2009.05.002
Li M, Zhang DQ, Wang XZ, Xu TJ (2011) NR2B-containing NMDA
receptors promote neural progenitor cell proliferation through
CaMKIV/CREB pathway. Biochem Biophys Res Commun 411:
667–672. https://doi.org/10.1016/j.bbrc.2011.06.170
Lisachev PD, ShtarkMB, Sokolova OO, Pustylnyak VO, Salakhutdinova
MY, Epstein OI (2010) A Comparison of the dynamics of S100B,
S100A1, and S100A6 mRNA expression in hippocampal CA1 area
of rats during long-term potentiation and after low-frequency stim-
ulation. Cardiovasc Psychiatry Neurol 2010:720958. https://doi.org/
10.1155/2010/720958
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data
using real-time quantitative PCR and the 2(−Delta Delta C(T)) meth-
od. Methods 25:402–408. https://doi.org/10.1006/meth.2001.1262
Lynch DR, Shim SS, Seifert KM, Kurapathi S, Mutel V, Gallagher MJ,
Guttmann RP (2001) Pharmacological characterization of interac-
tions of Ro 25-6981 with the NR2B (epsilon2) subunit. Eur J
Pharmacol 416:185–195. https://doi.org/10.1016/S0014-2999(01)
00868-8
Ming G, Song H (2011) Adult neurogenesis in the mammalian brain:
significant answers and significant questions. Neuron 70:687–702.
https://doi.org/10.1016/j.neuron.2011.05.001
Nácher J, McEwen BS (2006) The role of N-methyl-D-asparate receptors
in neurogenesis. Hippocampus 16:267–270. https://doi.org/10.
1002/hipo.20160
Nácher J, Alonso-Llosa G, Rosell DR, McEwen BS (2003) NMDA re-
ceptor antagonist treatment increases the production of new neurons
in the aged rat hippocampus. Neurobiol Aging 24:273–284. https://
doi.org/10.1016/S0197-4580(02)00096-9
Nácher J, Varea E, Miguel Blasco-Ibáñez J, Gómez-Climent MA,
Castillo-Gómez E, Crespo C, Martínez-Guijarro FJ, McEwen BS
(2007) N-methyl-D-aspartate receptor expression during adult
neurogenesis in the rat dentate gyrus. Neuroscience 144:855–864.
https://doi.org/10.1016/j.neuroscience.2006.10.021
Nader K, Hardt O (2009) A single standard for memory: the case for
reconsolidation. Nat Rev Neurosci 10:224–234. https://doi.org/10.
1038/nrn2590
Nakazawa K, McHugh TJ, Wilson MA, Tonegawa S (2004) NMDA
receptors, place cells and hippocampal spatial memory. Nat Rev
Neurosci 5:361–372. https://doi.org/10.1038/nrn1385
Nicola Z, Fabel K, Kempermann G (2015) Development of the adult
neurogenic niche in the hippocampus of mice. Front Neuroanat 9:
53. https://doi.org/10.3389/fnana.2015.00053
Okuyama N, Takagi N, Kawai T, Miyake-Takagi K, Takeo S (2004)
Phosphorylation of extracellular-regulating kinase in NMDA recep-
tor antagonist-induced newly generated neurons in the adult rat den-
tate gyrus. J Neurochem 88:717–725. https://doi.org/10.1046/j.
1471-4159.2003.02215.x
Opendak M, Gould E (2015) Adult neurogenesis: a substrate for
experience-dependent change. Trends Cogn Sci 19:151–161.
https://doi.org/10.1016/j.tics.2015.01.001
Reeber SL, Otis TS, Sillitoe RV (2013) New roles for the cerebellum in
health and disease. Front Syst Neurosci 7:83. https://doi.org/10.
3389/fnsys.2013.00083
Richetin K, Leclerc C, Toni N, Gallopin T, Pech S, Roybon L, Rampon C
(2015) Genetic manipulation of adult-born hippocampal neurons
rescues memory in a mouse model of Alzheimer’s disease. Brain
138(Pt 2):440–455
Roux C, Aligny C, Lesueur C, Girault V, Brunel V, Ramdani Y, Genty D,
Driouich A, Laquerrière A, Marret S, Brasse-Lagnel C, Gonzalez
BJ, Bekri S (2015) NMDA receptor blockade in the developing
cortex induces autophagy-mediated death of immature cortical
GABAergic interneurons: an ex vivo and in vivo study in Gad67-
GFP mice. Exp Neurol 267:177–193. https://doi.org/10.1016/j.
expneurol.2015.02.037
Sewell RDE, Gruden MA, Pache DM, Storozeva ZI, Kostanyan IA,
Proshin AT, Yurasov VV, Sherstnev VV (2005) Does the human
leukaemia differentiation factor fragment HLDF6 improve memory
via brain DNA and protein synthesis? J Psychopharmacol 19:602–
608. https://doi.org/10.1177/0269881105056645
Shefferly N (2005) BPan troglodytes^ (on-line), Animal diversity web.
Accessed April 20, 2018 at http://animaldiversity.org/accounts/Pan_
troglodytes
Shinohara K, Hata T (2018) Post-acquisition hippocampal blockade of
the NMDA receptor subunit GluN2A but not GluN2B sustains spa-
tial reference memory retention. Neurobiol Learn Mem 147:1–8.
https://doi.org/10.1016/j.nlm.2017.11.001
Snyder JS, Hong NS, McDonald RJ, Wojtowicz JM (2005) A role for
adult neurogenesis in spatial long-term memory. Neuroscience 130:
843–852. https://doi.org/10.1016/j.neuroscience.2004.10.009
Soloviova OA, Storozheva ZI, Proshin AT, Sherstnev VV (2011) Effects
of the neurogenesis stimulator Ro 25-6981 upon formation of spatial
skill in adult rats depend on the term of its administration and the
animals’ ability to learn. Rossiĭskii Fiziologicheskiĭ Zhurnal Imeni
I.M. Sechenova / Rossiĭskaia Akademiia Nauk 97:146–154
Soloviova OA, Proshin AT, Storozheva ZI, Sherstnev VV (2012)
Neurogenesis enhancer RO 25-6981 facilitates repeated spatial
learning in adult rats. Bull Exp Biol Med 153:764–766. https://doi.
org/10.1007/s10517-012-1821-6
Storozheva ZI, Gruden MA, Proshin AT, Sewell RDE (2015) Learning
ability is a key outcome determinant of GSK-3 inhibition on visuo-
spatial memory in rats. J Psychopharmacol 29:822–835. https://doi.
org/10.1177/0269881115573805
Swinny JD, van der Want JJ, Gramsbergen A (2005) Cerebellar develop-
ment and plasticity: perspectives for motor coordination strategies,
for motor skills, and for therapy. Neural Plast 12:153–160; discus-
sion 263-272. https://doi.org/10.1155/NP.2005.153
Szczurowska E, Mareš P (2015) Different action of a specific NR2B/
NMDA antagonist Ro 25-6981 on cortical evoked potentials and
epileptic afterdischarges in immature rats. Brain Res Bull 111:1–8.
https://doi.org/10.1016/j.brainresbull.2014.11.001
Thakurela S, Sahu SK, Garding A, Tiwari VK (2015) Dynamics and
function of distal regulatory elements during neurogenesis and
neuroplasticity. Genome Res 25:1309–1324. https://doi.org/10.
1101/gr.190926.115
Toda T, Gage FH (2018) Review: adult neurogenesis contributes to hip-
pocampal plasticity. Cell Tissue Res. https://doi.org/10.1007/
s00441-017-2735-4
Trent S, Barnes P, Hall J, Thomas KL (2015) Rescue of long-term mem-
ory after reconsolidation blockade. Nat Commun 6:7897. https://doi.
org/10.1038/ncomms8897.
Zhou HX, Wollmuth LP (2017) Advancing NMDA receptor physiology
by integrating multiple approaches. Trends Neurosci 40:129–137.
https://doi.org/10.1016/j.tins.2017.01.001
J Mol Neurosci
